INS and prediabetes syndrome: Taking into consideration glucose homeostasis, mirabegron treatment improved oral glucose tolerance, leading to convert prediabetes into normal glucose concentration, reduced hemoglobin A1c levels, and improved insulin sensitivity and β cell function, without affecting fasting blood glucose or fasting insulin levels and HOMA-IR.